MARCH 15, 2024
Notice to attend the 2024 Annual General Meeting on April 26
Key News
MARCH 13, 2024
Orexo has successfully issued secured social bonds of SEK 500 m
MARCH 8, 2024
IWD 2024 - Leading with purpose: Why Cecilia became an Orexo executive
Orexo has established a social financing framework
A commercial stage pharmaceutical company with three revenue generating pharmaceutical products
Development pipeline targeting large medical needs
AmorphOX® - a novel world leading nasal delivery technology leading to a new wave of products